ORCHID PHARMA
|
The Current P/S Ratio of ORCHID PHARMA is 7.42.
| Share Price | ₹1,004.6 | Aug 07,2026 |
| Market Cap | ₹6,017.6 Cr | |
| Sales-TTM | ₹811.3 Cr | TTM-Consolidated Results |
| Price/Sales | 7.42x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of ORCHID PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹6,017.6 Cr] as on Aug 07,2026
(/) Sales [ ₹811.3 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 7.42x ]
Thus, for ORCHID PHARMA , the investors are currently willing to pay '7.42 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ORCHID PHARMA !
The chart below summarizes the trend in P/S Ratio of ORCHID PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of ORCHID PHARMA
PS Ratio Performance Analysis for ORCHID PHARMA
- ORCHID PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 7.51x.
- ORCHID PHARMA 's operated at median p/e ratio of 4.27x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ORCHID PHARMA 's p/e ratio peaked in Mar2021 at 22.36x.
- ORCHID PHARMA 's p/e ratio hit its five-year low in Mar2022 of 2.07x.
How does ORCHID PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| ORCHID PHARMA | 811.3 | 7.42 | 6,017.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.82 | 468,530.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 19.56 | 219,675.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 11.89 | 186,970.0 |
| CIPLA LTD | 28,324.4 | 4.16 | 117,947.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.91 | 96,601.2 |
| MANKIND PHARMA LTD | 14,737.9 | 6.83 | 100,688.0 |
| LUPIN LTD | 29,966.6 | 3.47 | 104,021.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.12 | 111,790.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.71 | 94,707.2 |
| LAURUS LABS LTD | 7,269.6 | 13.87 | 100,822.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ORCHID PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.71x |
| Max industry PS | 19.56x |
| Median industry PS | 6.83x |
| Average industry PS | 7.71x |
You may also like the below Video Courses